NCT05950139
- Conditions
- ALK Fusion Protein Expression, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
- Locations
-
- Johns Hopkins University Baltimore, Maryland, United States
Clinical trial condition
ALK Fusion Protein Expression
Explore clinical trials studying ALK Fusion Protein Expression. Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
ALK Fusion Protein Expression trial results
Not Yet Recruiting
A Study Comparing Ensatinib Versus Platinum-Based Chemotherapy as Adjuvant Treatment for Stage II-IIIA ALK -Positive Non-Small Cell Lung Cancer
NCT05186506
- Conditions
- ALK Fusion Protein Expression, Adjuvant Therapy, Bronchial Neoplasms, +10 more
- Locations
-
Not specified